Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Accolade Inc (ACCD)

Accolade Inc (ACCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 727,635
  • Shares Outstanding, K 77,408
  • Annual Sales, $ 363,140 K
  • Annual Income, $ -459,650 K
  • 60-Month Beta 2.08
  • Price/Sales 1.79
  • Price/Cash Flow N/A
  • Price/Book 1.62
Trade ACCD with:

Options Overview Details

View History
  • Implied Volatility 99.06% ( +0.27%)
  • Historical Volatility 48.86%
  • IV Percentile 99%
  • IV Rank 73.54%
  • IV High 117.46% on 04/18/24
  • IV Low 47.91% on 08/31/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3,541
  • Volume Avg (30-Day) 342
  • Put/Call OI Ratio 2.80
  • Today's Open Interest 23,557
  • Open Int (30-Day) 24,583

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/29/24
See More
  • Average Estimate -0.11
  • Number of Estimates 9
  • High Estimate -0.01
  • Low Estimate -0.18
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +73.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.92 +16.04%
on 04/15/24
10.68 -13.95%
on 03/28/24
-0.50 (-5.16%)
since 03/25/24
3-Month
7.92 +16.04%
on 04/15/24
13.93 -34.03%
on 02/12/24
-2.97 (-24.42%)
since 01/25/24
52-Week
6.33 +45.18%
on 11/01/23
17.00 -45.96%
on 04/27/23
-6.78 (-42.45%)
since 04/25/23

Most Recent Stories

More News
Accolade: Fiscal Q4 Earnings Snapshot

Accolade: Fiscal Q4 Earnings Snapshot

ACCD : 9.19 (-2.23%)
Accolade: Fiscal Q3 Earnings Snapshot

Accolade: Fiscal Q3 Earnings Snapshot

ACCD : 9.19 (-2.23%)
1 Market-Beating Stock to Buy Near Its 52-Week High

This stock has been firing on all cylinders -- and it isn't about to stop.

NVO : 125.79 (-0.29%)
ACCD : 9.19 (-2.23%)
LLY : 724.87 (-1.00%)
Why Eli Lilly Stock Crawled Higher Today

The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift.

WFC : 59.93 (-1.11%)
NVO : 125.79 (-0.29%)
ACCD : 9.19 (-2.23%)
LLY : 724.87 (-1.00%)
GLP-1 Coverage in Employer Plans Could Nearly Double in 2024

/PRNewswire/ -- Accolade (Nasdaq: ACCD) announced today findings from an employer survey on sentiment and adoption of GLP-1 medications. A key finding: while...

ACCD : 9.19 (-2.23%)
Why Shares of Accolade Fell This Week

The company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.

ACCD : 9.19 (-2.23%)
Accolade: Fiscal Q2 Earnings Snapshot

Accolade: Fiscal Q2 Earnings Snapshot

ACCD : 9.19 (-2.23%)
Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

/PRNewswire/ -- Accolade (Nasdaq: ACCD) announced the expansion of its care delivery team, strengthening the company's ability to streamline healthcare...

ACCD : 9.19 (-2.23%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor went stock shopping on the final trading day in August.

MS : 92.56 (-1.37%)
PLTR : 21.71 (+0.56%)
NTLA : 20.02 (-5.43%)
ACCD : 9.19 (-2.23%)
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again

The famous growth investor has been making some interesting stock moves lately.

NTLA : 20.02 (-5.43%)
CRSP : 53.73 (-3.45%)
ACCD : 9.19 (-2.23%)
RXRX : 7.84 (-1.26%)
NVTA : 0.0195 (+2.63%)
ARKK : 43.61 (-0.66%)
ARKG : 23.01 (-2.79%)
NVDA : 826.32 (+3.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Accolade Inc. provides personalized, technology-enabled solutions which help people better understand, navigate and utilize the healthcare system. Accolade Inc. is based in SEATTLE.

See More

Key Turning Points

3rd Resistance Point 10.00
2nd Resistance Point 9.70
1st Resistance Point 9.45
Last Price 9.19
1st Support Level 8.90
2nd Support Level 8.60
3rd Support Level 8.35

See More

52-Week High 17.00
Fibonacci 61.8% 12.93
Fibonacci 50% 11.67
Fibonacci 38.2% 10.41
Last Price 9.19
52-Week Low 6.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar